Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-047522

Chief Business Officer bought 14,705 shares at $6.80 ($99,959)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Loerop James Chief Business Officer 2023-08-28 Purchase +14,705 $6.80 $99,959 21,688 D
Open-market purchases · 14,705 sh · avg $6.80 · $99,959
Loading xslF345X05/doc4.xml…